References

Understanding aneurysmal type 1 neovascularization (polypoidal choroidal vasculopathy): a lesson in the taxonomy of ‘expanded spectra’—a review

10.1111/ceo.13114 · 2018 · External reference

Polypoidal choroidal vasculopathy

10.1016/s0896-1549(02)00053-6 · 2002 · External reference

EVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy

10.1136/bjophthalmol-2014-305674 · 2015 · External reference

Polypoidal choroidal vasculopathy in elderly Chinese patients

10.1007/s00417-003-0667-z · 2004 · External reference

Clinical characteristics of exudative age-related macular degeneration in Japanese patients

10.1016/j.ajo.2007.03.047 · 2007 · External reference

Prevalence of polypoidal choroidal vasculopathy in white patients with exudative age-related macular degeneration: systematic review and meta-analysis

10.1097/iae.0000000000001872 · 2018 · External reference

Anti-vascular endothelial growth factor resistance in exudative macular degeneration and polypoidal choroidal vasculopathy

10.1016/j.oret.2019.04.018 · 2019 · External reference

Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: a randomized clinical trial

10.1001/jamaophthalmol.2017.4030 · 2017 · External reference

New paradigms in polypoidal choroidal vasculopathy management: the impact of recent multicenter, randomized clinical trials

10.3928/23258160-20171215-01 · 2018 · External reference

Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy in the PLANET study a randomized clinical trial

10.1001/jamaophthalmol.2018.1804 · 2018 · External reference

Comparison of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: the EVEREST II randomized clinical trial

10.1001/jamaophthalmol.2020.2443 · 2020 · External reference

Polypoidal choroidal vasculopathy: definition, pathogenesis, diagnosis, and management

10.1016/j.ophtha.2017.11.019 · 2018 · External reference

Posttreatment polyp progression and risk of massive submacular hemorrhage in eyes with polypoidal choroidal vasculopathy

10.1097/iae.0000000000002384 · 2020 · External reference

The polyp regression rate and treatment prognosis of different interventions for polypoidal choroidal vasculopathy: a systematic review and meta-analysis

10.1007/s00417-020-04977-1 · 2021 · External reference

Polypoidal choroidal vasculopathy causing massive suprachoroidal haemorrhage

10.1038/sj.eye.6702455 · 2007 · External reference

Polypoidal choroidal vasculopathy: natural history

10.1016/s0002-9394(02)01404-6 · 2002 · External reference

Results of vitrectomy for breakthrough vitreous hemorrhage associated with age-related macular degeneration and polypoidal choroidal vasculopathy

10.1097/iae.0b013e3181c969e9 · 2010 · External reference

Visual outcomes and prognostic factors of large submacular hemorrhages secondary to polypoidal choroidal vasculopathy

10.2147/opth.s327138 · 2021 · External reference

Massive submacular haemorrhage in polypoidal choroidal vasculopathy versus typical neovascular age-related macular degeneration

2020 · External reference

A novel classification of the vascular patterns of polypoidal choroidal vasculopathy and its relation to clinical outcomes

10.1136/bjophthalmol-2014-305059 · 2014 · External reference

EVEREST report 5: clinical outcomes and treatment response of polypoidal choroidal vasculopathy subtypes in a multicenter, randomized controlled trial

10.1167/iovs.17-22683 · 2018 · External reference

Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin

10.1001/archopht.1995.01100060136048 · 1995 · External reference

Ranibizumab for treatment of neovascular age-related macular degeneration. A phase I/II multicenter, controlled, multidose study

10.1016/j.ophtha.2005.10.052 · 2006 · External reference

Ranibizumab for neovascular age-related macular degeneration

10.1056/nejmoa054481 · 2006 · External reference